US Pharma MarketingNovartis
Manufacturing roundup: Novartis licenses Alteogen Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and…
Plus, news about Novonesis, Aspen, Fortrea and Northway.
Alteogen and Novartis make a deal: The Swiss pharma is licensing Alteogen’s hyaluronidase enzyme, called ALT-B4, which is manufactured using a tech platform ...
Source: Endpoints News